Reproductive Phenotypes and Genotypes in Men With IHH

Overview

Journal J Clin Endocrinol Metab

Publisher Oxford University Press

Specialty Endocrinology

Date 2022 Oct 21

PMID 36268624

Authors

Andrew A Dwyer

Maria I Stamou

Ella Anghel

Shira Hornstein

Danna Chen

Kathryn B Salnikov

Isabella R McDonald

Lacey Plummer

Stephanie B Seminara

Ravikumar Balasubramanian

Affiliations

Soon will be listed here.

Abstract

Context: Isolated hypogonadotropic hypogonadism (IHH) is phenotypically and genetically heterogeneous.

Objective: This work aimed to determine the correlation between genotypic severity with pubertal and neuroendocrine phenotypes in IHH men.

Methods: A retrospective study was conducted (1980-2020) examining olfaction (Kallmann syndrome [KS] vs normosmic IHH [nHH]), baseline testicular volume (absent vs partial puberty), neuroendocrine profiling (pulsatile vs apulsatile luteinizing hormone [LH] secretion), and genetic variants in 62 IHH-associated genes through exome sequencing (ES).

Results: In total, 242 men (KS: n = 131 [54%], nHH: n = 111 [46%]) were included. Men with absent puberty had significantly lower gonadotropin levels (P < .001) and were more likely to have undetectable LH (P < .001). Logistic regression showed partial puberty as a statistically significant predictor of pulsatile LH secretion (R2 = 0.71, P < .001, OR: 10.8; 95% CI, 3.6-38.6). Serum LH of 2.10 IU/L had a 95% true positive rate for predicting LH pulsatility. Genetic analyses in 204 of 242 IHH men with ES data available revealed 36 of 204 (18%) men carried protein-truncating variants (PTVs) in 12 IHH genes. Men with absent puberty and apulsatile LH were enriched for oligogenic PTVs (P < .001), with variants in ANOS1 being the predominant PTV in this genotype-phenotype association. Men with absent puberty were enriched for ANOS1 PTVs compared to partial puberty counterparts (P = .002). PTVs in other IHH genes imparted more variable reproductive phenotypic severity.

Conclusion: Partial puberty and LH greater than or equal to 2.10 IU/L are proxies for pulsatile LH secretion. ANOS1 PTVs confer severe reproductive phenotypes. Variable phenotypic severity in the face of severe genetic variants in other IHH genes point to significant neuroendocrine plasticity of the HPG axis in IHH men.

Citing Articles

Lack of a genetic risk continuum between pubertal timing in the general population and idiopathic hypogonadotropic hypogonadism.

Plummer L, Balasubramanian R, Stamou M, Campbell M, Dewan P, Bryant N J Neuroendocrinol. 2024; 36(10):e13445.

PMID: 39256164 PMC: 11444870. DOI: 10.1111/jne.13445.

Current landscape of fertility induction in males with congenital hypogonadotropic hypogonadism.

Dwyer A, McDonald I, Quinton R Ann N Y Acad Sci. 2024; 1540(1):133-146.

PMID: 39190467 PMC: 11471374. DOI: 10.1111/nyas.15214.

Case report: Novel SIN3A loss-of-function variant as causative for hypogonadotropic hypogonadism in Witteveen-Kolk syndrome.

Correa Brito L, Keselman A, Villegas F, Scaglia P, Azcoiti M, Castro S Front Genet. 2024; 15:1354715.

PMID: 38528912 PMC: 10961356. DOI: 10.3389/fgene.2024.1354715.

Classes and predictors of reversal in male patients with congenital hypogonadotropic hypogonadism: a cross-sectional study of six international referral centres.

Dwyer A, McDonald I, Cangiano B, Giovanelli L, Maione L, Silveira L Lancet Diabetes Endocrinol. 2024; 12(4):257-266.

PMID: 38437850 PMC: 10996025. DOI: 10.1016/S2213-8587(24)00028-7.

References

Spratt D, Carr D, Merriam G, Scully R, Rao P, Crowley Jr W . The spectrum of abnormal patterns of gonadotropin-releasing hormone secretion in men with idiopathic hypogonadotropic hypogonadism: clinical and laboratory correlations. J Clin Endocrinol Metab. 1987; 64(2):283-91. DOI: 10.1210/jcem-64-2-283. View

Lewkowitz-Shpuntoff H, Hughes V, Plummer L, Au M, Doty R, Seminara S . Olfactory phenotypic spectrum in idiopathic hypogonadotropic hypogonadism: pathophysiological and genetic implications. J Clin Endocrinol Metab. 2011; 97(1):E136-44. PMC: 3251934. DOI: 10.1210/jc.2011-2041. View

Pitteloud N, Meysing A, Quinton R, Acierno Jr J, Dwyer A, Plummer L . Mutations in fibroblast growth factor receptor 1 cause Kallmann syndrome with a wide spectrum of reproductive phenotypes. Mol Cell Endocrinol. 2006; 254-255:60-9. DOI: 10.1016/j.mce.2006.04.021. View

Miraoui H, Dwyer A, Sykiotis G, Plummer L, Chung W, Feng B . Mutations in FGF17, IL17RD, DUSP6, SPRY4, and FLRT3 are identified in individuals with congenital hypogonadotropic hypogonadism. Am J Hum Genet. 2013; 92(5):725-43. PMC: 3644636. DOI: 10.1016/j.ajhg.2013.04.008. View

Pitteloud N, Hayes F, Dwyer A, Boepple P, Lee H, Crowley Jr W . Predictors of outcome of long-term GnRH therapy in men with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab. 2002; 87(9):4128-36. DOI: 10.1210/jc.2002-020518. View

Karczewski K, Francioli L, Tiao G, Cummings B, Alfoldi J, Wang Q . The mutational constraint spectrum quantified from variation in 141,456 humans. Nature. 2020; 581(7809):434-443. PMC: 7334197. DOI: 10.1038/s41586-020-2308-7. View

Cassatella D, Howard S, Acierno J, Xu C, Papadakis G, Santoni F . Congenital hypogonadotropic hypogonadism and constitutional delay of growth and puberty have distinct genetic architectures. Eur J Endocrinol. 2018; 178(4):377-388. PMC: 5863472. DOI: 10.1530/EJE-17-0568. View

Stamou M, Brand H, Wang M, Wong I, Lippincott M, Plummer L . Prevalence and Phenotypic Effects of Copy Number Variants in Isolated Hypogonadotropic Hypogonadism. J Clin Endocrinol Metab. 2022; 107(8):2228-2242. PMC: 9282252. DOI: 10.1210/clinem/dgac300. View

Sykiotis G, Plummer L, Hughes V, Au M, Durrani S, Nayak-Young S . Oligogenic basis of isolated gonadotropin-releasing hormone deficiency. Proc Natl Acad Sci U S A. 2010; 107(34):15140-4. PMC: 2930591. DOI: 10.1073/pnas.1009622107. View

10.

Laitinen E, Vaaralahti K, Tommiska J, Eklund E, Tervaniemi M, Valanne L . Incidence, phenotypic features and molecular genetics of Kallmann syndrome in Finland. Orphanet J Rare Dis. 2011; 6:41. PMC: 3143089. DOI: 10.1186/1750-1172-6-41. View

11.

Francou B, Bouligand J, Voican A, Amazit L, Trabado S, Fagart J . Normosmic congenital hypogonadotropic hypogonadism due to TAC3/TACR3 mutations: characterization of neuroendocrine phenotypes and novel mutations. PLoS One. 2011; 6(10):e25614. PMC: 3198730. DOI: 10.1371/journal.pone.0025614. View

12.

Costa-Barbosa F, Balasubramanian R, Keefe K, Shaw N, Al-Tassan N, Plummer L . Prioritizing genetic testing in patients with Kallmann syndrome using clinical phenotypes. J Clin Endocrinol Metab. 2013; 98(5):E943-53. PMC: 3644607. DOI: 10.1210/jc.2012-4116. View

13.

Boehm U, Bouloux P, Dattani M, de Roux N, Dode C, Dunkel L . Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism--pathogenesis, diagnosis and treatment. Nat Rev Endocrinol. 2015; 11(9):547-64. DOI: 10.1038/nrendo.2015.112. View

14.

Young J, Xu C, Papadakis G, Acierno J, Maione L, Hietamaki J . Clinical Management of Congenital Hypogonadotropic Hypogonadism. Endocr Rev. 2019; 40(2):669-710. DOI: 10.1210/er.2018-00116. View

15.

Sykiotis G, Hoang X, Avbelj M, Hayes F, Thambundit A, Dwyer A . Congenital idiopathic hypogonadotropic hypogonadism: evidence of defects in the hypothalamus, pituitary, and testes. J Clin Endocrinol Metab. 2010; 95(6):3019-27. PMC: 2902061. DOI: 10.1210/jc.2009-2582. View

16.

Salenave S, Chanson P, Bry H, Pugeat M, Cabrol S, Carel J . Kallmann's syndrome: a comparison of the reproductive phenotypes in men carrying KAL1 and FGFR1/KAL2 mutations. J Clin Endocrinol Metab. 2007; 93(3):758-63. DOI: 10.1210/jc.2007-1168. View

17.

Doty R, Shaman P, DANN M . Development of the University of Pennsylvania Smell Identification Test: a standardized microencapsulated test of olfactory function. Physiol Behav. 1984; 32(3):489-502. DOI: 10.1016/0031-9384(84)90269-5. View

18.

Dwyer A, Raivio T, Pitteloud N . MANAGEMENT OF ENDOCRINE DISEASE: Reversible hypogonadotropic hypogonadism. Eur J Endocrinol. 2016; 174(6):R267-74. DOI: 10.1530/EJE-15-1033. View

19.

Waldstreicher J, Seminara S, Jameson J, Geyer A, Nachtigall L, Boepple P . The genetic and clinical heterogeneity of gonadotropin-releasing hormone deficiency in the human. J Clin Endocrinol Metab. 1996; 81(12):4388-95. DOI: 10.1210/jcem.81.12.8954047. View

20.

Santen R, Bardin C . Episodic luteinizing hormone secretion in man. Pulse analysis, clinical interpretation, physiologic mechanisms. J Clin Invest. 1973; 52(10):2617-28. PMC: 302522. DOI: 10.1172/JCI107454. View